I believe the European financial market contains too much risk, and one should rather invest in the American financial system because it has a lot more upward potential. I wrote that in one of my latest articles. However, there is one exception to my statement: UBS Group (NYSE:UBS). The Swiss banking group is especially strong in investment banking and asset management and will probably outperform....More>>>
Small cap diabetes stocks Oramed Pharmaceuticals, Inc (NASDAQ: ORMP), Senseonics Holdings (NYSEMKT: SENS) and Cell MedX Corp (OTCQB: CMXC) might not immediately come to mind when you think of the disease. However, theres plenty of room in the market place for players of all sizes. Just consider some quick statistics about diabetes compiled by Cell MedX Corp:
In 2016, 415 million adults....More>>>
German property stocks have had a good year, which reflects two things: (1) strong dynamics in German property, primarily based on solid economic growth (ECB forecasts ~1.6% real GDO growth through 2018) and (2) negative ECB deposit rates, which lower financing costs for developers and landlord while also forcing institutional buyers (insurance companies, pension funds and asset managers) into real....More>>>
On Thursday, our Under the Radar Moversnewsletter suggestedgoing long on small cap clinical-stage biopharmaceutical cancer stock Bellicum Pharmaceuticals (NASDAQ: BLCM):
This entry is probably a little sooner than we’d normally like to get into a budding rebound. But, we’d rather be early than late this time around. As of this week, BLCM shares are above February high, further....More>>>
The comparison between Snap (NYSE:SNAP) and Facebook (NASDAQ:FB) is inevitable. Snap went public this past Thursday, and the stock has been up 65% from the IPO price of $17/share in a matter of days. Meanwhile, the Menlo Park company went public in May 2012 and, unlike Snap, its IPO (priced at $38/share) struggled to gain traction in the early days. FB’s shares lost about half their market....More>>>
Click to enlarge
Source: Stock Photo
There have been several articles concerning Enterprise Products Partners, Inc. (NYSE:EPD) recently, which focus a lot on the technicals and the near-term performance of the company. In my view, it’s safe to completely ignore them, as they’re not something any investor taking a position in the pipeline and storage company should make....More>>>
Shares of auction house Sotheby’s (NYSE:BID) jumped as much as 14.7% in trading Monday after the company released fourth-quarter results. And shares kept steaming, trading 13.6% higher as of 12:30 p.m. EST.
Revenue for the quarter fell 8.1% to $308.7 million, but the company did swing from a loss of $11.2 million to a profit of $65.5 million,....More>>>
We listened to Cempra (NASDAQ: CEMP) management’s investor conference call after receiving the Complete Response Letter (CRL) from the FDA regarding regulatory application for Solithromycin’s approval for the treatment of adult community-acquired bacterial pneumonia (CABP). The management plans to meet with the FDA to discuss FDA’s request for a comparative safety trial to study....More>>>
China appears to be sending a message to President-elect Donald Trump: Good luck competing against us on manufacturing.
Mere hours after Trump, Vice President-elect Mike Pence and Carrier announced a deal to keep nearly 1,000 factory jobs in the U.S., a top Chinese newspaper published an analysis piece with the headline: “China would benefit from Trump’s effort to bring manufacturing....More>>>
Stop making it so complicated! A friend said to me yesterday, "I was thinking about selling stocks now – ahead of the election – and then buying them back afterward." Hey, that's fine, whatever makes him happy. But that's not an investing strategy… that's a speculation. It's not based on an understanding of the markets. Today, I want....More>>>